Artisan Partners
VIR icon

Artisan Partners’s Vir Biotechnology VIR Stock Holding History

Artisan Partners’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-791,611
Closed -$3.99M – 373
2025
Q2 		$3.99M Hold
791,611
– – 0.01% 325
2025
Q1 		$5.13M Sell
791,611
-126,918
-14% -$1.13M 0.01% 321
2024
Q4 		$6.74M Buy
+918,529
New +$7.24M 0.01% 330

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Artisan Partners's VIR Position: Q3 2025 in Review

Artisan Partners sold out of Vir Biotechnology (VIR) in Q3 2025, closing a stake of 791,611 shares — an estimated $3.99M sold.

Artisan Partners first reported a position in VIR in Q4 2024 and held it in 3 quarters. The position peaked at $6.74M in Q4 2024. 213 funds tracked by Wall St. Rank hold VIR as of Q3 2025.

  • Artisan Partners reported no remaining Vir Biotechnology position as of Q3 2025 after selling out during the quarter.
  • Artisan Partners sold 791,611 Vir Biotechnology shares in Q3 2025, an estimated $3.99M.
  • Artisan Partners first reported a position in Vir Biotechnology in Q4 2024 and held it in 3 quarters.
  • Artisan Partners's Vir Biotechnology position peaked at $6.74M in Q4 2024.
  • 213 funds tracked by Wall St. Rank held Vir Biotechnology as of Q3 2025.

Based on Artisan Partners's 13F filing for Q3 2025, filed 12 Nov 2025.